Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Absci Corporation is a biopharmaceutical company specializing in AI-driven antibody drug creation. Its Integrated Drug Creation platform combines generative AI, synthetic biology, and high-throughput wet-lab validation to design and optimize novel antibody therapeutics, including against hard-to-drug targets. Absci develops internally owned programs and partners with pharmaceutical and biotech firms, aiming to accelerate biologic drug discovery, improve success rates, and generate milestone and royalty revenues across diverse therapeutic areas.
This description was generated via AI from an annual report. Updated about 1 year ago.